Back
Arcellx Vs. Blueprint Medicines Industry Stock Comparison
Sell
50
ACLX
Arcellx
Last Price:
$70.24
Seasonality Move:
14.17%
Buy
55
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
2.89%
Sell
50
Arcellx (ACLX)
is a Sell
Is Arcellx a Buy, Sell or Hold?
-
ACLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACLX Stock Price Chart
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
ACLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.45 | Buy |
Relative Strength Index (14 RSI): | 58.45 | Buy |
Chaikin Money Flow: | -153335 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.21 - 70.09) | Buy |
Bollinger Bands (100): | (60.32 - 69.68) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.8 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.32 - 129.44) | Buy |
Bollinger Bands (100): | (87.11 - 124.89) | Buy |
ACLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 69.79 | Buy |
20-day SMA: | 68.5 | Buy |
50-day SMA: | 65.68 | Buy |
200-day SMA: | 71.85 | Sell |
8-day EMA: | 69.94 | Buy |
20-day EMA: | 68.6 | Buy |
50-day EMA: | 66.59 | Buy |
200-day EMA: | 67.02 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.46 | Sell |
20-day SMA: | 129.04 | Buy |
50-day SMA: | 122.45 | Buy |
200-day SMA: | 100.81 | Buy |
8-day EMA: | 129.4 | Buy |
20-day EMA: | 128.51 | Buy |
50-day EMA: | 121.79 | Buy |
200-day EMA: | 104.98 | Buy |
Arcellx Earnings Growth & ACLX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.78 per share, an increase next quarter of $0.27 per share, a decrease this year of $2.50 per share, and an increase next year of $0.61 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Arcellx Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |